At 8 months follow-up, patients with painful diabetic peripheral neuropathy who received spinal cord stimulation (SCS) implants reported improvements in pain, neuropathic and autonomic symptoms, ...

The MarketWatch News Department was not involved in the creation of this content. Real-time insights reveal BIOTRONIK Neuro's remote monitoring with remote programming led to high rates of therapy use ...

Nevro Corp. NVRO recently announced the publication of 24-month data from the SENZA Painful Diabetic Neuropathy (PDN) Randomized Controlled Trial (RCT) in Diabetes Research and Clinical Practice. The ...

Spinal cord stimulation (SCS) to treat pain in persons with multiple sclerosis (MS) was the focus of a recent literature review out of Italy. An analysis from Italy of 7 studies that investigated ...

Evidence Published in Diabetes Research and Clinical Practice Shows 10 kHz Therapy Yields Lasting Pain Relief and Enhances Health-Related Quality of Life and Sleep Published 24-month data from the ...

Researchers from the University of Cambridge have built a minimally invasive, ultra-thin, inflatable spinal cord stimulation (SCS) device that could be used to relieve some of the most severe forms of ...

The new implant is essentially a type of advanced spinal cord stimulator, which are devices that sit in between the spinal cord and the vertebrate and emit electrical pulses that disrupt pain signals.

Evidence Published in Diabetes Research and Clinical Practice Shows 10 kHz Therapy Yields Lasting Pain Relief and Enhances Health-Related Quality of Life and Sleep Globally, the number of people with ...

Real-time insights reveal BIOTRONIK Neuro's remote monitoring with remote programming led to high rates of therapy use and lower explant rates LAKE OSWEGO, Ore., Jan. 5, 2026 /PRNewswire/ -- A new ...